XML 83 R51.htm IDEA: XBRL DOCUMENT
v2.4.1.9

4. Goodwill and other Purchased Intangible Assets Intangible Assets, Goodwill and Other (Details) (USD $) | 12 Months Ended | 3 Months Ended
--- | --- | ---
Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2012
Goodwill [Roll Forward] |  |  |  |
Goodwill period start | $ 546,000,000 us-gaap_GoodwillGross | $ 523,600,000 us-gaap_GoodwillGross |  |
Accumulated impairment loss period start | (28,200,000)us-gaap_GoodwillImpairedAccumulatedImpairmentLoss | (28,200,000)us-gaap_GoodwillImpairedAccumulatedImpairmentLoss |  |
Goodwill, net period start | 517,770,000 us-gaap_Goodwill | 495,400,000 us-gaap_Goodwill |  |
Goodwill, Acquired During Period | 13,500,000 us-gaap_GoodwillAcquiredDuringPeriod | 14,900,000 us-gaap_GoodwillAcquiredDuringPeriod |  |
Goodwill, Written off Related to Sale of Business Unit | 0 us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit | 0 us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit | (1,000,000)us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit |
Currency fluctuations | (30,900,000)us-gaap_GoodwillTranslationAdjustments | 7,500,000 us-gaap_GoodwillTranslationAdjustments |  |
Goodwill period end | 528,600,000 us-gaap_GoodwillGross | 546,000,000 us-gaap_GoodwillGross | 523,600,000 us-gaap_GoodwillGross | 523,600,000 us-gaap_GoodwillGross
Accumulated impairment loss period end | (28,200,000)us-gaap_GoodwillImpairedAccumulatedImpairmentLoss | (28,200,000)us-gaap_GoodwillImpairedAccumulatedImpairmentLoss | (28,200,000)us-gaap_GoodwillImpairedAccumulatedImpairmentLoss | (28,200,000)us-gaap_GoodwillImpairedAccumulatedImpairmentLoss
Goodwill, net period end | 500,441,000 us-gaap_Goodwill | 517,770,000 us-gaap_Goodwill | 495,400,000 us-gaap_Goodwill | 495,400,000 us-gaap_Goodwill
Life Science [Member] |  |  |  |
Goodwill [Roll Forward] |  |  |  |
Goodwill period start | 209,000,000 us-gaap_GoodwillGross / us-gaap_StatementBusinessSegmentsAxis = bio_LifeScienceMember | 193,600,000 us-gaap_GoodwillGross / us-gaap_StatementBusinessSegmentsAxis = bio_LifeScienceMember |  |
Accumulated impairment loss period start | (27,200,000)us-gaap_GoodwillImpairedAccumulatedImpairmentLoss / us-gaap_StatementBusinessSegmentsAxis = bio_LifeScienceMember | (27,200,000)us-gaap_GoodwillImpairedAccumulatedImpairmentLoss / us-gaap_StatementBusinessSegmentsAxis = bio_LifeScienceMember |  |
Goodwill, net period start | 181,800,000 us-gaap_Goodwill / us-gaap_StatementBusinessSegmentsAxis = bio_LifeScienceMember | 166,400,000 us-gaap_Goodwill / us-gaap_StatementBusinessSegmentsAxis = bio_LifeScienceMember |  |
Goodwill, Acquired During Period | 0 us-gaap_GoodwillAcquiredDuringPeriod / us-gaap_StatementBusinessSegmentsAxis = bio_LifeScienceMember | 14,900,000 us-gaap_GoodwillAcquiredDuringPeriod / us-gaap_StatementBusinessSegmentsAxis = bio_LifeScienceMember |  |
Currency fluctuations | (1,300,000)us-gaap_GoodwillTranslationAdjustments / us-gaap_StatementBusinessSegmentsAxis = bio_LifeScienceMember | 500,000 us-gaap_GoodwillTranslationAdjustments / us-gaap_StatementBusinessSegmentsAxis = bio_LifeScienceMember |  |
Goodwill period end | 207,700,000 us-gaap_GoodwillGross / us-gaap_StatementBusinessSegmentsAxis = bio_LifeScienceMember | 209,000,000 us-gaap_GoodwillGross / us-gaap_StatementBusinessSegmentsAxis = bio_LifeScienceMember |  |
Accumulated impairment loss period end | (27,200,000)us-gaap_GoodwillImpairedAccumulatedImpairmentLoss / us-gaap_StatementBusinessSegmentsAxis = bio_LifeScienceMember | (27,200,000)us-gaap_GoodwillImpairedAccumulatedImpairmentLoss / us-gaap_StatementBusinessSegmentsAxis = bio_LifeScienceMember |  |
Goodwill, net period end | 180,500,000 us-gaap_Goodwill / us-gaap_StatementBusinessSegmentsAxis = bio_LifeScienceMember | 181,800,000 us-gaap_Goodwill / us-gaap_StatementBusinessSegmentsAxis = bio_LifeScienceMember |  |
Clinical Diagnostics [Member] |  |  |  |
Goodwill [Roll Forward] |  |  |  |
Goodwill period start | 337,000,000 us-gaap_GoodwillGross / us-gaap_StatementBusinessSegmentsAxis = bio_ClinicalDiagnosticsMember | 330,000,000 us-gaap_GoodwillGross / us-gaap_StatementBusinessSegmentsAxis = bio_ClinicalDiagnosticsMember |  |
Accumulated impairment loss period start | (1,000,000)us-gaap_GoodwillImpairedAccumulatedImpairmentLoss / us-gaap_StatementBusinessSegmentsAxis = bio_ClinicalDiagnosticsMember | (1,000,000)us-gaap_GoodwillImpairedAccumulatedImpairmentLoss / us-gaap_StatementBusinessSegmentsAxis = bio_ClinicalDiagnosticsMember |  |
Goodwill, net period start | 336,000,000 us-gaap_Goodwill / us-gaap_StatementBusinessSegmentsAxis = bio_ClinicalDiagnosticsMember | 329,000,000 us-gaap_Goodwill / us-gaap_StatementBusinessSegmentsAxis = bio_ClinicalDiagnosticsMember |  |
Goodwill, Acquired During Period | 13,500,000 us-gaap_GoodwillAcquiredDuringPeriod / us-gaap_StatementBusinessSegmentsAxis = bio_ClinicalDiagnosticsMember | 0 us-gaap_GoodwillAcquiredDuringPeriod / us-gaap_StatementBusinessSegmentsAxis = bio_ClinicalDiagnosticsMember |  |
Goodwill, Written off Related to Sale of Business Unit |  |  |  | (1,000,000)us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit / us-gaap_StatementBusinessSegmentsAxis = bio_ClinicalDiagnosticsMember
Currency fluctuations | (29,600,000)us-gaap_GoodwillTranslationAdjustments / us-gaap_StatementBusinessSegmentsAxis = bio_ClinicalDiagnosticsMember | 7,000,000 us-gaap_GoodwillTranslationAdjustments / us-gaap_StatementBusinessSegmentsAxis = bio_ClinicalDiagnosticsMember |  |
Goodwill period end | 320,900,000 us-gaap_GoodwillGross / us-gaap_StatementBusinessSegmentsAxis = bio_ClinicalDiagnosticsMember | 337,000,000 us-gaap_GoodwillGross / us-gaap_StatementBusinessSegmentsAxis = bio_ClinicalDiagnosticsMember | 330,000,000 us-gaap_GoodwillGross / us-gaap_StatementBusinessSegmentsAxis = bio_ClinicalDiagnosticsMember | 330,000,000 us-gaap_GoodwillGross / us-gaap_StatementBusinessSegmentsAxis = bio_ClinicalDiagnosticsMember
Accumulated impairment loss period end | (1,000,000)us-gaap_GoodwillImpairedAccumulatedImpairmentLoss / us-gaap_StatementBusinessSegmentsAxis = bio_ClinicalDiagnosticsMember | (1,000,000)us-gaap_GoodwillImpairedAccumulatedImpairmentLoss / us-gaap_StatementBusinessSegmentsAxis = bio_ClinicalDiagnosticsMember | (1,000,000)us-gaap_GoodwillImpairedAccumulatedImpairmentLoss / us-gaap_StatementBusinessSegmentsAxis = bio_ClinicalDiagnosticsMember | (1,000,000)us-gaap_GoodwillImpairedAccumulatedImpairmentLoss / us-gaap_StatementBusinessSegmentsAxis = bio_ClinicalDiagnosticsMember
Goodwill, net period end | $ 319,900,000 us-gaap_Goodwill / us-gaap_StatementBusinessSegmentsAxis = bio_ClinicalDiagnosticsMember | $ 336,000,000 us-gaap_Goodwill / us-gaap_StatementBusinessSegmentsAxis = bio_ClinicalDiagnosticsMember | $ 329,000,000 us-gaap_Goodwill / us-gaap_StatementBusinessSegmentsAxis = bio_ClinicalDiagnosticsMember | $ 329,000,000 us-gaap_Goodwill / us-gaap_StatementBusinessSegmentsAxis = bio_ClinicalDiagnosticsMember

X
- Definition Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 45 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6388280&loc=d3e13770-109266 + Details
Name: | us-gaap_Goodwill
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267 + Details
Name: | us-gaap_GoodwillAcquiredDuringPeriod
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount before accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (a,h) -URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267 + Details
Name: | us-gaap_GoodwillGross
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (a,h) -URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267 + Details
Name: | us-gaap_GoodwillImpairedAccumulatedImpairmentLoss
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Details
Name: | us-gaap_GoodwillRollForward
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of increase (decrease) from foreign currency translation adjustments of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (f) -URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267 + Details
Name: | us-gaap_GoodwillTranslationAdjustments
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of divestiture of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (d) -URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267 + Details
Name: | us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=bio_ClinicalDiagnosticsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=bio_LifeScienceMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |